SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Giancarlo Maria Liumbruno, Massimo Franchini, Solvent/detergent plasma: pharmaceutical characteristics and clinical experience, Journal of Thrombosis and Thrombolysis, 2015, 39, 1, 118

    CrossRef

  2. 2
    R. Cardigan, L. Green, Thawed and liquid plasma – what do we know?, Vox Sanguinis, 2015, 108, 4
  3. 3
    Daniel Bolliger, Eckhard Mauermann, Kenichi A. Tanaka, Thresholds for Perioperative Administration of Hemostatic Blood Components and Coagulation Factor Concentrates: An Unmet Medical Need, Journal of Cardiothoracic and Vascular Anesthesia, 2015, 29, 3, 768

    CrossRef

  4. 4
    Johannes Irsch, Jerard Seghatchian, Update on pathogen inactivation treatment of plasma, with the INTERCEPT Blood System: Current position on methodological, clinical and regulatory aspects, Transfusion and Apheresis Science, 2015,

    CrossRef

  5. 5
    Kathleen L. Bagot, Barbara M. Masser, Katherine M. White, Using an Extended Theory of Planned Behavior to Predict a Change in the Type of Blood Product Donated, Annals of Behavioral Medicine, 2015,

    CrossRef

  6. 6
    Peter Schubert, Brankica Culibrk, Simrath Karwal, Katherine Serrano, Elena Levin, Daniel Bu, Varsha Bhakta, William P. Sheffield, Raymond P. Goodrich, Dana V. Devine, Whole blood treated with riboflavin and ultraviolet light: quality assessment of all blood components produced by the buffy coat method, Transfusion, 2015, 55, 4
  7. 7
    Debra T. Liu, Deborah C. Silverstein, Small Animal Critical Care Medicine, 2015,

    CrossRef

  8. 8
    O. Garraud, P. Chavarin, F. Boussoulade, P. Morata, S. Rochette-Eribon, S. Acquart, P. Fabrigli, C. Argaud, V. Bost, F. Cognasse, Les différents types de plasmas thérapeutiques sont-ils équivalents ?, Transfusion Clinique et Biologique, 2014, 21, 1, 31

    CrossRef

  9. 9
    Kasey Sze-Kei Chan, Rosemary L. Sparrow, Microparticle profile and procoagulant activity of fresh-frozen plasma is affected by whole blood leukoreduction rather than 24-hour room temperature hold, Transfusion, 2014, 54, 8
  10. 10
    H. B. Feys, B. Aelst, K. Devreese, R. Devloo, J. Coene, P. Vandekerckhove, V. Compernolle, Oxygen removal during pathogen inactivation with riboflavin and UV light preserves protein function in plasma for transfusion, Vox Sanguinis, 2014, 106, 4
  11. 11
    José Coene, Katrien Devreese, Bea Sabot, Hendrik B. Feys, Philippe Vandekerckhove, Veerle Compernolle, Paired analysis of plasma proteins and coagulant capacity after treatment with three methods of pathogen reduction, Transfusion, 2014, 54, 5
  12. 12
    S. Labarinas, D. Arni, O. Karam, Transfusions de plasma en réanimation pédiatrique, Réanimation, 2014, 23, 4, 455

    CrossRef

  13. 13
    Aryeh Shander, Edward A. Michelson, Babak Sarani, Matthew L. Flaherty, Ira A. Shulman, Use of Plasma in the Management of Central Nervous System Bleeding: Evidence-Based Consensus Recommendations, Advances in Therapy, 2014, 31, 1, 66

    CrossRef

  14. 14
    Ingrid Veldhuizen, Anne Dongen, Motivational differences between whole blood and plasma donors already exist before their first donation experience, Transfusion, 2013, 53, 8
  15. 15
    Brian M Elliott, Louis M Aledort, Restoring hemostasis: fibrinogen concentrate versus cryoprecipitate, Expert Review of Hematology, 2013, 6, 3, 277

    CrossRef

  16. 16
    M. Naderi, P. Eshghi, E. Saneei Moghaddam, SH. Alizadeh, A. Dorgalaleh, M. R. Younesi, Z. K. Khateb, Safety of human blood products in rare bleeding disorders in southeast of Iran, Haemophilia, 2013, 19, 2
  17. 17
    Z. M. Szczepiorkowski, N. M. Dunbar, Transfusion guidelines: when to transfuse, Hematology, 2013, 2013, 1, 638

    CrossRef

  18. 18
    David M. Lin, Linda S. Murphy, Minh-Ha Tran, Use of Prothrombin Complex Concentrates and Fibrinogen Concentrates in the Perioperative Setting: A Systematic Review, Transfusion Medicine Reviews, 2013, 27, 2, 91

    CrossRef